T2 Biosystems, Inc.

TTOO · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Operating Activities
Net Income-$10-$9-$14-$10
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$1
Stock-Based Comp.$0$0$2$1
Change in WC$1$0-$1-$1
Other Non-Cash$3-$1$1$2
Operating Cash Flow-$6-$9-$12-$9
Investing Activities
PP&E Inv.$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$4$7$2$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$0$0
Financing Cash Flow$4$7$2$1
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$2-$9-$9
Supplemental Information
Beg. Cash$4$6$16$24
End Cash$3$4$6$16
Free Cash Flow-$6-$9-$12-$9
T2 Biosystems, Inc. (TTOO) Financial Statements & Key Stats | AlphaPilot